Preliminary report of the effects of complement suppression with pexelizumab on neurocognitive decline after coronary artery bypass graft surgery. - Mathew,JP.; Shernan,SK.; White,WD.; Fitch,JC.; Chen,JC.; Bell,L.; Newman,MF. (Stroke, 2004)